Sidley has advised Shanghai Pharmaceuticals Holding Co. Ltd. (HKEX: 2607) (SSE: 601607) (SPH) on its joint venture with Phililab, Inc. (Phililab) through its Delaware subsidiary, SPH…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
